Automation can have positive effects in many different areas, such as case intake, duplicate check, follow up, narrative generation, quality check or end-to-end processing. But which one are you most likely to automate?
On November 28, 2017, ArisGlobal held a webinar with DIA, “How Automation Can Deliver the Holy Grail in Safety: Achieve Productivity, Compliance and Quality”. In this webinar, we posed a few questions to the audience, and came up with some interesting information. We took this and spent some thinking about what this means to our clients in the PV ecosystem.
Artificial intelligence (AI), machine learning, deep learning, natural language processing – in short, cognitive computing, is changing the pharmacovigilance world as we know it. While there’s a lot of talk about how AI will affect jobs, where it will have the most powerful impact is on the quality of work and the speed at which manual tasks can be accomplished.
Managing and Mastering Pharmacovigilance covers how LifeSphere Multivigilance 10 benefits small to medium-sized businesses by utilizing industry-standard practices and proper management processes.
A key offering in ArisGlobal’s LifeSphere platform, LifeSphere Reporter empowers field reps, provides fields teams and approved users with secure access, and easily integrates with LSMV10 and other systems.
ArisGlobal believes that there is no single “right place to start” when it comes to automation, and life sciences organizations must instead choose their own adventure when it comes to a sound PV-focused automation strategy. Read part two of our three-part blog series.
ArisGlobal, part of the more cautious and highly regulated life science go “all-in on AWS” by moving the entire cloud infrastructure to the AWS platform. This move benefits both ArisGlobal and to our customers.
On June 16th, 2020, ArisGlobal participated in the 2020 DIA ...
This is the first in a four-part blog series that examines the Clinical, Medical Affairs, Regulatory, and Safety product domains at ArisGlobal. Senior Director of Clinical Product Management, Sondra Pepe, describes what attracted her to ArisGlobal and articulated the vision for Clinical product strategy.
During our recent webinar, when polled 43% of the audience said automating PV processes was one of their top strategic priorities, while 13% have no automation plan in place. That and other interesting insights are shared in this first of a three-part blog series.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved
